Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Gastroenterology|December 29, 2011
Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survivalStephanie Roessler, Ezhou Lori Long, Anuradha Budhu, et al.
Oncogene|February 15, 2020
NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesisSarah Luiken, Angelika Fraas, Matthias Bieg, et al.
Cell Death & Disease|October 29, 2024
Proteomic profiling reveals CEACAM6 function in driving gallbladder cancer aggressiveness through integrin receptor, PRKCD and AKT/ERK signalingRaisatun Nisa Sugiyanto, Carmen Metzger, Aslihan Inal, et al.
Gut|January 20, 2021
Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesisBenjamin Goeppert, Damian Stichel, Reka Toth, et al.
Virchows Archiv : an International Journal of Pathology|December 16, 2019
HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinomaThomas Albrecht, Melina Rausch, Stephanie Roessler, et al.
Nature Communications|May 16, 2019
Nucleoporin Nup155 is part of the p53 network in liver cancerKerstin Holzer, Alessandro Ori, Amy Cooke, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 28, 2022
Trip13 Depletion in Liver Cancer Induces a Lipogenic Response Contributing to Plin2-Dependent Mitotic Cell DeathMarcos Rios Garcia, Bettina Meissburger, Jessica Chan, et al.
Cancer Research|October 22, 2020
YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver TumorigenesisStefan Thomann, Sofia M E Weiler, Simone Marquard, et al.
Oncotarget|April 19, 2017
Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomasDarko Castven, Michael Fischer, Diana Becker, et al.
Science Advances|December 22, 2023
Chromosome 8p engineering reveals increased metastatic potential targetable by patient-specific synthetic lethality in liver cancerThorben Huth, Emely C Dreher, Steffen Lemke, et al.
Pageof 12